Vivitra Trastuzumab Lyophilized Powder

About Vivitra Trastuzumab Lyophilized Powder

Vivitra Trastuzumab Lyophilized Powder is a recombinant humanized monoclonal antibody used in the treatment of HER2-positive breast cancer and gastric cancer. It works by specifically targeting the HER2 receptor, helping to inhibit the growth and spread of cancer cells that overexpress this protein. This formulation is supplied as a sterile, lyophilized powder for reconstitution before intravenous administration.

Widely prescribed by oncologists, Vivitra Trastuzumab is known for its targeted action, clinical efficacy, and reliability in cancer therapy when used as per approved treatment protocols.

• Targeted monoclonal antibody therapy

• Effective against HER2-positive cancers

• High purity lyophilized formulation

• Ensures consistent therapeutic performance

• Suitable for hospital and clinical use

• Active Ingredient: Trastuzumab

• Dosage Form: Lyophilized powder for injection

• HER2-positive breast cancer

• HER2-positive metastatic gastric or gastroesophageal junction cancer

• For intravenous use only

• To be administered under the supervision of a qualified healthcare professional

• Store in a refrigerator at 2C to 8C

• Do not freeze

• Protect from light

• Prescription medicine; use strictly as directed by an oncologist

• Monitor cardiac function during therapy as advised

• Not recommended for self-medication

Packaging:

• Vial (with lyophilized powder)